SCHEMBL7793672

SCHEMBL7793672

CCCCOC(=O)CCCCC(CCS)C(=O)CCSC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.42
DNM1 Q05193 1/20 0.40
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
MAPT P10636 1/20 0.35
PLA2G2A P14555 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PAM P19021 2/20 0.33
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793676 0.78 DGKA (0.45) DGKADNM1CYP3A4TSHRATM
SCHEMBL2196519 0.77 DGKA (0.62) DGKADNM1TSHRPRSS1PRSS2
SCHEMBL7792766 0.76 DGKA (0.43) DGKADNM1CYP3A4TSHRATM
SCHEMBL16173927 0.76 DGKA (0.53) DGKADNM1TSHRATMPRSS1
SCHEMBL8095315 0.76 DGKA (0.51) DGKADNM1CYP3A4TSHRATM
SCHEMBL6742895 0.73 DGKA (0.64) DGKADNM1CYP3A4TSHRATM
SCHEMBL18429952 0.72 DGKA (0.65) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL187111 0.72 DGKA (0.59) DGKADNM1CYP3A4TSHRATM
SCHEMBL3918716 0.72 DGKA (0.56) DGKADNM1PRSS1PRSS2PRSS3
SCHEMBL2193854 0.72 DGKA (0.56) DGKADNM1PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0947503-B1 6,8-Dimethylmercaptooctanoic acid derivatives substituted on 6-S and/or 8-S by the 3-methylthiopropanoyl radical and pharmaceutical compositions for the treatment of cancerous tumours GALDERMA RES & DEV (FR) 2001-11-21 EP claimed